KRAS and endometrioid adenocarcinoma: The predominant histological subtype is endometrioid carcinoma, harboring frequent mutations in PTEN (52–78%), PIK3CA (36–52%), KRAS (15–43%), ARID1A (25–48%), and CTNNB1 (23–24%).